Copyright
©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5598-5606
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5598
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5598
Category | 3-yr recurrence-free survival rate | Univariate analysis | Multivariate analysis | 3-yr OS rate | Univariate analysis | Multivariate analysis |
P value | P value and HR (95%CI) | P value | P value and HR (95%CI) | |||
Gender | 0.382 | 0.834 | ||||
Male | 55.8% | 0.751 | 1.381 | 83.7% | 0.981 | 1.121 |
Female | 57.1% | 0.670-2.849 | 85.7% | 0.385-3.267 | ||
Age, yr | 0.100 | 0.765 | ||||
< 60 | 57.3% | 0.496 | 1.508 | 83.4% | 0.763 | 0.887 |
≥ 60 | 51.2% | 0.925-2.460 | 86.0% | 0.402-1.954 | ||
Smoking | 0.136 | 0.618 | ||||
Yes | 51.5% | 0.076 | 1.482 | 83.8% | 0.374 | 1.237 |
No | 58.3% | 0.883-2.485 | 84.1% | 0.536-2.854 | ||
Drinking | 0.525 | 0.338 | ||||
Yes | 52.2% | 0.443 | 0.829 | 87.0% | 0.740 | 0.632 |
No | 57.1% | 0.466-1.477 | 83.1% | 0.247-1.615 | ||
Family history | 0.199 | 0.091 | ||||
Yes | 66.7% | 0.237 | 0.497 | 91.7% | 0.165 | 0.170 |
No | 55.3% | 0.171-1.444 | 83.5% | 0.022-1.325 | ||
HBsAg status | 0.0101 | 0.266 | ||||
Negative | 82.1% | 0.006 | 3.019 | 92.9% | 0.057 | 2.374 |
Positive | 51.7% | 1.309-6.959 | 82.6% | 0.517-10.895 | ||
AFP, ng/mL | 0.279 | 0.972 | ||||
> 400 | 54.4% | 0.184 | 0.782 | 82.7% | 0.948 | 1.012 |
≤ 400 | 58.7% | 0.501-1.220 | 84.8% | 0.508-2.018 | ||
Hepatic cirrhosis | 0.635 | 0.0131 | 0.0311 | |||
Yes | 53.4% | 0.176 | 1.128 | 80.4% | 3.233 | |
No | 63.5% | 0.686-1.853 | 94.2% | 1.110-9.417 | ||
CTP class | 0.0321 | 0.147 | ||||
A | 58.1% | 0.011 | 2.130 | 83.9% | 0.262 | 2.321 |
B | 28.6% | 1.068-4.246 | 85.7% | 0.745-7.233 | ||
Delta-NLR | 0.0191 | 0.146 | ||||
> 1.643 | 50.0% | 0.009 | 1.807 | 81.4% | 0.161 | 1.765 |
≤ 1.643 | 68.4% | 1.102-2.962 | 89.5% | 0.820-3.799 | ||
Tumor nodules | 0.891 | 0.625 | ||||
Single | 57.5% | 0.339 | 0.960 | 83.9% | 0.396 | 1.26 |
Multiple | 46.2% | 0.530-1.736 | 84.6% | 0.499-3.185 | ||
Maximal tumor diameter | 0.056 | 0.0191 | ||||
> 5 cm | 47.4% | 0.075 | 1.573 | 75.4% | 0.0251 | 2.281 |
≤ 5 cm | 59.4% | 0.989-2.503 | 87.4% | 1.148-4.536 | ||
Vascular invasion | 0.176 | 0.598 | 0.163 | 0.792 | ||
Yes | 53.8% | 0.828 | 76.9% | 1.144 | ||
No | 56.3% | 0.411-1.669 | 85.1% | 0.420-3.113 | ||
Concomitant splenectomy | 0.721 | 0.308 | ||||
Yes | 37.5% | 0.061 | 0.939 | 75.0% | 0.343 | 0.757 |
No | 57.6% | 0.665-1.326 | 84.8% | 0.444-1.292 | ||
Intra-abdominal infection | 0.0001 | 0.0001 | ||||
Yes | 24.0% | < 0.001 | 3.308 | 52.0% | < 0.0011 | 5.357 |
No | 60.6% | 1.806-6.061 | 88.6% | 2.494-11.507 |
- Citation: Ruan DY, Lin ZX, Li Y, Jiang N, Li X, Wu DH, Wang TT, Chen J, Lin Q, Wu XY. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy. World J Gastroenterol 2015; 21(18): 5598-5606
- URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5598.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5598